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ABSTRACT
Background: Extra intestinal manifestations of inflammatory bowel
disease (IBD) are a systemic illness that may affect up to half of all
patients. Among the extra intestinal manifestations of IBD, those
involving respiratory system are relatively rare. However, there is a wide
variation of such manifestations, spanning from airway disease to lung
parenchymal disease, pleural disease, enteric pulmonary fistulas and
pulmonary function test abnormalities. This study aimed to detect the
abnormalities of pulmonary function tests in inflammatory bowel
diseases in children Method: A prospective Cross sectional study was
carried out at Gastro entrology unit and pulmonary unit pediatric
department, in Zagazig University hospitals during the period from
December 2016 to January 2018. Twenty patients with inflammatory
bowel disease were recruited in the study and full history and clinical
examination was taken. full lab was drawn such as complete blood count,
C reactive protein, erythrocyte sedimentation rate. Pulmonary function
tests (PFTs) was performed with spirometer. Statistical analysis was
done for these data. Results: PFT was abnormal in 40% patients.
abnormal PFT was classifed into restrictive 6 (30%), and obstructive
defects 2 (10%) .IBD patients with active disease have abnormal
pulmonary function tests .No relation of PFT abnormalities was found
with age, sex, duration of disease, serum albumin, and hemoglobin
levels, and other extraintestinal manifestation (arthritis/arthralgia) and
drugs used to treat IBD. Conclusion: the study proved that IBD patients
with active disease have abnormal pulmonary functions with
predominant involvement of restrictive. Active IBD was more often
associated with abnormal PFT than the disease in remission.
Keywords: inflammatory bowel disease, extra intestinal manifestation
and abnormal PFT

INTRODUCTION
nflammatory bowel diseases (IBDs) are
chronic gastrointestinal tract diseases of
unknown etiology [1] .IBD presenting with
diarrhea that almost always contains blood,
fatigue, anemia, and weight loss. The onset of
symptoms may be insidious, with diarrhea
that is initially non-bloody, and poor weight
gain. Some children have a more fulminant
presentation, with severe abdominal pain,
frankly bloody diarrhea, tenesmus, fever,
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leukocytosis, and hypoalbuminemia [2] .More
than one-third of the IBD patients are affected
[3]
by extraintestinal manifestations
.Pulmonary manifestations have been reported
in IBD patients, such as inflammatory
tracheal stenosis, bronchiolitis obliterans
organizing pneumonia, panbronchiolitis,
interstitial pneumonitis, and apical fibrosis[4].
The
relationship
between
pulmonary
impairment and activity of disease also has
not been clearly established in IBD patients.
38 | P a g e
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Some authors report that pulmonary function
test (PFT) abnormalities in the patients of
IBD are associated with the activity of
disease.[1] This study aimed to detect the
abnormalities of pulmonary function tests in
inflammatory bowel diseases in children.
METHODS
A prospective Cross sectional study was
carried out at Gastro entrology unit and
pulmonary unit pediatric department, Zagazig
University hospitals during the period from
December 2016 to January 2018 . Twenty
patients with inflammatory bowel disease)
were enrolled for this study, all were used to
extract demographic and outcome data . We
used these data for analysis, we measured
pulmonary function test for all children at the
day of admission.16 children were diagnosed
as ulcerative colitis , 4 children were
diagnosed as crohn disease .
The study was approved by the research
ethical committee of Faculty of Medicine,
Zagazig University. The work has been
carried out in accordance with The Code of
Ethics of the World Medical Association
(Declaration of Helsinki) for studies involving
humans
Patient: Inclusion criteria: were Children
diagnosed as inflammatory bowel diseases By
endoscopy and Histopathology were involved
in our study from both sexes with age range
from4-18y, Exclusion criteria: were Patients
with chronic GIT problems other than
IBD,with any neurologic, cardiac, upper
airway troubles interfering with PFT
technique, with Chronic lung diseases were
excluded from this study.
Methods: Each Patient is subjected to
complete history taking including personal,
present history taking (duration of diseases
and type of drug with doses). past history of
disease, drug, operation and recurrence,
Diseases
activity
index.
Complete
examination for patients which is done for
assessment of body systems including general
examination for vital signs, measurement,
.Also
Chest
examination,
Abdomen
examination were done.
Investigation
:
routine
laboratory
investigation as CBC , CRP, ESR, Stool
analysis, stool calprotectin, KFT, and LFT
Hend A., et al….
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were done and other investigation as Chest X
ray, Barium studies and Colonoscopy , upper
endoscopy finding and PFT
Pulmonary function test: Pulmonary
function tests were assessed the day after
admission, during remission and relapse.
Pulmonary function testing were performed
with spirometer (2010 Ganshorn, Medizin
Electronic GmbH Industries, Trasse 6-8,
97618, Nieder Lauer, Germany. Software
version LF 8.5) to measure the predicted
forced vital capacity (FVC), the predicted
forced expiratory volume in1 s (FEV1), and
their ratio (FEV1/FVC) Normal physiology
was defined by all measurements being >80%
predicted, a restrictive defect as a reduced
(<80% predicted) FVC with an FEV1/FVC
ratio of >70% predicted or reduced DLCO
(<80% predicted), and an obstructive defect
as a reduced FEV1 with a normal FVC and a
low FEV1/FVC ratio (<70% predicted). Small
airway disease was defined as reduced FEV1
(<70% predicted), low FEV1/ FVC (<70%
predicted) ratio, and reduced MEF25–75 (<60
predicted) [5].
Disease activity: Patients with active disease
were classified as mild, moderate, or severe as
per Truelove score. This score includes stool
frequency, occurrence of blood in stools,
fever, hemoglobin (Hb) levels, and
erythrocyte sedimentation rate (ESR). Patients
were considered in clinical remission if they
had one or two stools a day without blood, no
fever, or tachycardia, along with normal Hb
determinations and ESR. [5]
Extent of disease: Extent of the disease was
assessed on colonoscopy as proctitis, leftsided colitis, or pan colitis. Proctitis was
defined as involvement of the rectum only,
left-sided colitis as left colon up to splenic
flexure and pancolitis as extensive disease
beyond splenic flexure.[5]
Ethical Clearance: Written Informed consent
was taken from the patient parents to
participate in the study. Approval for
performing the study was obtained from
Pediatrics Departments, Zagazig University
Hospitals after taking Institutional Review
Board (IRB) approval. The work has been
carried out in accordance with the code of
ethics of the world medical association
39 | P a g e
2

Abd-Elhamid et al.: Pulmonary Function Tests in children suffering from Inflammatory

January. 2021 Volume 27 Issue 1

(Decleration of Helsinki) for studies involving
humans.
Statistical analysis
Statistical analysis was performed using SPSS
version 15 (SPSS, Inc., Chicago, IL, USA).
Continuous data were expressed as median
and range. Continuous and categorical
variables were analyzed using Mann–Whitney
U-test and chisquare test with Yates’
correction as applicable, respectively.
Intergroup comparison of more than two
variables was performed using Kruskal–
Wallis H-test. Spearman or Pearson
correlation coefficient was used to find out
the relationship between the two continuous
variables depending on distribution of the
data.
All P values were based on a 2-tailed
distribution, and the corresponding
P value:

Non-significant (NS) difference if
P > 0.05.

Significant(S) difference if P <
0.05.

Highly significant (HS) difference
if P< 0.00.
RESULTS
Baseline characteristics were demonstrated in
table (1). The mean age±SD was 9±3.7 years,
and the majority were female (70%). Eighty
percent of cases had ulcerative colitis. Mean
body mass index (BMI) ±SD was 18.3±2.4
Pulmonary function tests of the studied (IBD)
patients were abnormal (40%),mostly
restrictive (30%)were demonstrated in table
(2).
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There is statistically significantly strong
positive
correlation
existed
between
frequency of attack of relapse and FVC/FEV1
ratio (P=.024).No statistically significant
differences between other relevant study
parameters and FVC/FEV1 ratio of the
studied (IBD) patients (P>.05) was shown
table (3).
There is Statistically significantly moderate
negative correlations existed between body
mass index, frequency of attack of relapse and
FEV1% (P=.036 and P=.007, respectively).
However,
no
statistically
significant
differences between other relevant study
parameters and FEV1% of the studied (IBD)
patients (P>.05), was shown in table (4).
Patients with abnormal pulmonary functions
had statistically significantly lower body mass
index than patients with normal pulmonary
functions (P=.020).Also, there was a
statistically significant association between
pulmonary function and colonoscopy biopsy
findings (P=.028). However, no statistically
significant differences between other relevant
study parameters and pulmonary function of
the studied (IBD) patients (P>.05), was
shown in table (5).
A scatter plot with a regression line of
FEV1% against body mass index of the
studied (IBD) patients was shown in figure
(1).
A scatter plot with a regression line of
FEV1/FVC ratio against frequency of attack
of relapse of the studied (IBD) patients was
shown in figure (2).
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Table 1: Demographics of the studied (IBD) patients
Variables
mean±SD
median(range)
Sex, n (%)
Female
Male
Residency, n(%)
Urban
Rural
Age of onset (years)
mean±SD
median(range)
Weight (kg)
mean±SD
median(range)
Height(cm)
mean±SD
median(range)
BMI (kg/m2)
mean±SD
median(range)
BMI, body mass index; Total number=20.

10.21608/zumj.2019.18291.1591

Age (years)
9±3.7
8(4-15)
14(70)
6(30)
8(40)
12(60)
6.5±3.9
5.8(0.5-13)
24.8±9.0
23(12-42)
114.5±17.3
110(80-150)
18.3±2.4
17.8(15.4-24.1)

Table 2: Pulmonary function tests of the studied (IBD) patients
Variables
FVC%
mean±SD
median(range)
FEV1%

78.7±5.7
80(66-87)

mean±SD
median(range)
FEV1/FVC ratio
mean±SD

78.2±3.1
79(70-82)
1±0.05

median(range)
1(0.9-1.1)
Pulmonary function,n(%)
Normal
12(60)
Restrictive
6(30)
Obstructive
2(10)
FVC, forced vital capacity; FEV1, forced expiratory volume. Total number=20
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Table 3: Relations between relevant study parameters and FEV1/FVC ratio of the studied (IBD)
patients
Variables
BMI(kg/m2)
Frequency of attack of relapse
Main complain
Abdominal pain Abdominal pain and weight loss, n=4
*Other
and
bloody
complains,
diarrhea, n=5
n=11
1(0.9-1.1)
1(1-1.06)
1(0.94-1)
General examination
Weight loss, n=13
*Others, n=7
1(0.94-1.1)
Abdominal examination
Abdominal distension, n=8

Test
rs=.290
rs=.504
Kruskalwallis H
test=1.1

P-value
.22
.024
.57

Mann Whitney
U test=43.5

.88

Kruskalwallis H
test=5.7

.057

Kruskalwallis H
test=5.8

.056

1(0.9-1.10)
Abdominal
rigidity, n=7
1(0.9-1)

1(0.9-1.1)
Colonoscopy biopsy
Crypt abscess, n=7

Crypt abscess and
neutrophilic infiltrate,
n=7
1(0.9-1)

1(0.96-1.1)

*Others, n=5
1(1-1.1)
*others, n=6

1(1-1.04)

rs=.383
.095
Stool calprotectin (mg/kg)
a
BMI, body mass index; one patient was fissuring ulcers with excluded from the statistical analysis. Data are
median(range). rs, Spearman's rho correlation coefficient. *see table 3. Total number=20

Table 4: Relations between relevant study parameters and FEV1% of the studied (IBD) patients
Variables
BMI(kg/m2)
Frequency of attack of relapse
Main complain
Abdominal pain
Abdominal pain and weight loss, n=4
*Other
and
bloody
complains,
diarrhea, n=5
n=11
80(79-80)
78(78-79)
80(70-82)
General examination
Weight loss, n=13
*Others, n=7
80(70-82)
Abdominal examination
Abdominal distension, n=8
77±4.2
Colonoscopy biopsy
Crypt abscess, n=7

Test
rs=-.471
rs=-580
Kruskalwallis
H test=2.4

P-value
.036
.007
.30

Mann Whitney
U test=21.5

.056

78(73-81)
Abdominal
rigidity, n=7
79±2.3
Crypt abscess and
neutrophilic infiltrate,
n=7
80(78-81)

*Others, n=5

Welch's
ANOVA
F=0.80

.48

79±0.71
*others, n=6

Kruskalwallis
H test=2.1

.36

79(70-80)
77(73-82)
rs=.158
.51
Stool calprotectin (mg/kg)
BMI, body mass index; Data are mean±SD or median(range). rs, Spearman's rho correlation coefficient.*see
table 3.Total number=20
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Table 5: Relations between relevant study parameters and pulmonary function of the studied (IBD)
patients
Variables

Pulmonary function
Normal
n=12

BMI(kg/m2)
median(range)
Frequency of attack of
relapse, n
No relapse, n=8
≥ once a year, n=12
Main complain, n

17.3(15.4-19.2)

7(58)
5(42)

Abnormal
n=8
19.1(17.2-24.1)

3(25)

2(25)

3(25)

1(12)

6(50)

5(63)

Weight loss , n=13
Others, n=7
Abdominal examination,
n
Abdominal distension, n=8
Abdominal rigidity, n=7
*Others, n=5
Colonoscopy biopsy

9(75)
3(25)

Crypt abscess, n=7
Crypt
abscess
and
neutrophilic infiltrate, n=7
*others, n=6
Stool calprotectin (mg/kg)
median(range)

3(25)
7(58)

4(50)
0(0)

2(17)

4(50)

210(58-798)

P-value

Mann
Whitney U
test=18
Fisher's
Exact Test

.020

Fisher's
Exact
Test=0.62

.84

Fisher's
Exact Test

.36

Fisher's
Exact
Test=4.9

.099

Fisher's
Exact
Test=7.5

.028

Mann
Whitney U
test=31

.21

.07

1(13)
7(87)

Abdominal pain and bloody
diarrhea, n=5
Abdominal pain and weight
loss, n=4
*Other complains, n=11
General examination, n

5(42)
6(50)
1(8)

Test of
significance

4(50)
4(50)

3(38)
1(12)
4(50)

304 (120-1318)

BMI, body mass index;*see table 3.
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Figure 1. A scatter plot with a regression line of FVC% against body mass index of the studied
(IBD) patients

Figure 2. A scatter plot with a regression line of FEV1/FVC ratio against frequency of attack of
relapse of the studied (IBD) patients

DISCUSSION
Inflammatory bowel diseases (IBDs) are
chronic inflammatory diseases of unknown
etiology that commonly involve the
gastrointestinal tract. Crohn’s disease (CD)
and ulcerative colitis (UC) are the two main
forms of chronic IBD. Extra intestinal and
systemic manifestations occur commonly in
patients with IBD (21%-41%), increase with
duration of intestinal disease, and affect most
organ systems [6].
This study showed mean of age ± SD was
9±3.7 years in comparison to Peradzy_nska
et al. [7]. showed mean age 14.2 ± 3.2 yrs.
This study showed the majority of cases were
ulcerative colitis in comparison to Gut et al.,
Hend A., et al….
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[8]

. showed most cases were crohn disease.
This study showed mean body mass index
(BMI) ±SD was 18.3±2.4 in comparison to
Peradzy_nska et al. (2012)[7]. Found mean
BMI ±SD was 19.5±2.2 . This study showed
mean duration of disease (years) was 2.6±3.3
while Yilmaz et al [9]. showed Mean duration
of disease (years) 3 ± 0.5.
This study showed that frequency of relapse
classified as no relapse (40%), mild (35%),
moderate (20%) and sever (5%). In
comparison to Goyal A et al., [5]. Showed that
no relapse (58.6%), mild (15.8%), moderate
(23.7%), severe (60.5%), while Gut et al [8]
reported that no relapse (55.6%), moderate
(33.3%) and severe (11.1%).
44 | P a g e
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This study showed that medication used in
treatment of IBD were Sulphasalazine (50%),
Sulphasalazine and azathioprine (25%),
Sulphasalazine and steroid (15%), Steroid and
infliximab (5%) and Steroid, azathioprine,
infliximab and colectomy (5%) In comparison
to Goyal A et al.,[5]. Showed that ASA
(89.7%), Steroids (44.8%), Azathioprine
(18.4%),
Methotrexate
(2.3%)
and
Sulfasalazine (10.3%). Our study showed that
the most common Clinical findings were
Abdominal pain and bloody diarrhea (25%),
Abdominal pain and weight loss (20%).
Abdominal pain and growth failure (10%),
Abdominal pain, bloody diarrhea and weight
loss(10%) and Abdominal pain and bleeding
per rectum(5%) similar to Bequet E. et al.,
[10]
. Showed that clinical presentation
Abdominal pain, rectal bleeding, diarrhea,
anemia and growth failure. This study showed
that the most common Extra intestinal
manifestations were Weight loss and pallor
(20%), Weight loss (15%), Weight loss and
clubbing (10%), Oral ulcers and weight loss
(10%) and Uveitis, weight loss and pallor
while Ji XQ et al., [1]. Extra intestinal
manifestations were pyoderma gangrenosum
and erythema nodosum), ocular (anterior
uveitis
and
episcleritis),
hepatic
(pericholangitis and fatty liver), and articular
(peripheral and axial arthropathies) diseases.
Mouth ulcers and venous thrombosis also
occur.
This study showed that mean level of
hemoglobin 9.9±0.98 in comparison with
Goyal A et al. [5]. showed mean level 11
(6.7–15.3). 21.8±20.7 (mg/L) Our study
showed that mean level of C-reactive protein
While Gut et al [8] mean level 3.2 (0.7–11.4)
(mg/L). Our study showed that mean level of
erythrocyte sedimentation rate 44.7±19.2
(mm/hr) while Gut et al., [8] mean level
23.1±0.52 (12–38) (mm/hr).
This study reported that most cases were
normal chest radiography which normal chest
x ray (85%) and abnormal (15%) similar to
Yilmaz et al., [9] showed that chest x ray was
often normal in patients with respiratory
symptoms and IBD. Our study showed that
Colonoscopy biopsy findings were Crypt
abscess (35%), Crypt abscess and neutrophilic
Hend A., et al….
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infiltrate(35%), Neutrophilic infiltrate (10%),
Granuloma and neutrophilic infiltrate (10%)
and Granuloma and crypt abscess (5%)
similar to Bousvaros A., et al. [11] showed
that granuloma, crypt abscess, neutrophilic
infiltrate.
This study showed that Pulmonary function
tests of the studied (IBD) patients were mean
value of FVC% was 78.7±5.7 median (range)
was 80 (66-87), mean value of FEV1% was
78.2±3.1 median (range) was 79 (70-82)
median (range) was 1 (0.9-1.1) and mean
value of FEV1/FVC ratio (Tiffeneau value).
95±0.05 median (range) was 1 (0.9-1.1) in
comparison with Goyal A et al ., [5] showed
that median (range) of was FVC% 87 (49–
145) median (range) was of FEV1 89 (51–
171) and median (range) of FEV1/FVC
(Tiffeneau value) was 86 (63–120) and
Herrlinger et al.,[12] which showed mean
value of FEV1 (81.4 ±3.3%), mean value of
FVC (84.4 - 2.9%) and mean value of
FEV1/FVC (Tiffeneau value) (97.2±2.4%).
This study found that percentage of cases with
abnormal pulmonary function (restrictive
pattern) (30%) and (obstructive pattern)
(10%) agree with, Sethy et al.[13] reported
most
abnormal
pulmonary
function
(restrictive pattern) 16% of UC patients and
disagree Yilmaz et al.,[9] found that (7.69%)
patients had obstructive dysfunction, (5.12%)
had restrictive dysfunction, and (12.8%) had
abnormal diffusion, disagree with Godet et
al., [14] Also found PFT abnormalities,
obstructive pattern, abnormal DLCO, and
restrictive pattern in 53%, 22.7%, 28.8%, and
1.5% of patients with UC respectively.
This study showed that Statistically
significantly moderate negative correlations
existed between body mass index, frequency
of attack of relapse and FVC% in contrast
with Goyal A et al., [5] showed that BMI was
not significantly different in patients with
normal and abnormal PFT. While Herrlinger
et al. [12] found weak correlation between
inspiratory vital capacity (r = 0.25, P < 0.05)
and BMI but not for FEV1.
This study showed that FVC% was
statistically significantly different among IBD
patients grouped according colonoscopy
biopsy findings (P=.014).in comparison with
45 | P a g e
8

Abd-Elhamid et al.: Pulmonary Function Tests in children suffering from Inflammatory

January. 2021 Volume 27 Issue 1

Goyal A et al.,[5] showed that PFT values
were abnormal in (12.5%), (35.7), and
(28.6%) patients with proctitis, left-sided
colitis, and pan colitis, respectively.
This study showed that statistically
significantly moderate negative correlations
existed between body mass index, frequency
of attack of relapse and FEV1% (P=.036 and
P=.007, respectively). Goyal A et al .,[5]
showed that BMI was not significantly
different in patients with normal and
abnormal PFT. Herrlinger et al.[12] found no
correlation between FEV1% and BMI,
Yilmaz et al., [9]stated that there was no
correlation between BMI and pulmonary
function tests.
This study found that no statistically
significant differences between Colonoscopy
biopsy finding and PFT of the studied (IBD)
patients IN Contrast with Yilmaz et al., [9]
found association of increased respiratory
symptom score with high endoscopic activity
index in UC patients, but there was no
correlation between respiratory symptoms and
clinical activity of bowel disease. This study
found that No significant relationship was
found between duration of IBD and
pulmonary function test results agree with
Yilmaz et al.,[9] reported no relationship
between duration of disease and PFT results.
Yilmaz et al., [9] found that both the colonic
and respiratory epithelia share embryonic
origin from the primitive foregut. The
inflammatory lesions seen beneath the
bronchial epithelium are similar to those
observed beneath the colonic epithelium in
IBD. This means that there is inflammation
that can be detected early by HRCT and
pulmonary function tests. Although most
patients have subclinical disease, the
pulmonologist must be aware of the multiple
potential pulmonary manifestations that can
occur in a patient with IBD.
In the study by Louis et al., [15] patients with
IBD, free of pulmonary symptoms, which
similar to our study absence of pulmonary
symptoms in patients with IBD which showed
abnormal pulmonary function tests .
Goyal A et al., [5] found that Nutritional
status (BMI, serum albumin, and Hb) was not
significantly different in patients with normal
Hend A., et al….
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and abnormal PFT agree with our study no
significant relation between hemoglobin,
serum albumin and PFT In our study found
that (40%) of our cases reported abnormal
PFT most of them were restrictive pattern
while Mohamed-Hussein et al.,[16] fifteen
out of 26 patients with UC had an important
impairment in PFTs, Herrlinger et al.,[12] the
impairment in PFTs was more pronounced in
IBD patients with active disease than in those
with inactive disease, Sethy et al.,[13] found
deranged PFT in 17% patients with UC.
There was no relationship between treatment
of UC with different drugs and abnormal PFT
in our study which agree with Goyal A et al
.,[5] found no relationship between different
drugs for UC and PFT.
In This study found that FVC%, FEV1% and
FEV1/FVC ratio significantly decreased
during relapse compared to their values
before relapse (P<.05) which agree with
Mohamed-Hussein et al.,[16] found that
FEV1 and FVC significantly decreased in
patients with active disease as compared to
those with an inactive disease and Herrlinger
et al., [12] reported that decrease PFT during
relapse compared to those during remission
CONCLUSION
PFT abnormalities detected in patients with
inflammatory Bowel diseases, Most of PFT
abnormalities in This study were restrictive,
Activity of IBD disease affect PFT which a
non invasive diagnostic procedure in
determining the activation of IBD.
The present study has some limitations
including small number of patients and
inability to perform the pulmonary function
test for some children during excacerbations
It Is recommended that PFT should be done
for all cases of IBD to detect sub clinical
abnormalities to confirm our result, PFT
should be done for large scale of population
because a large proportion of symptom free
patients have abnormal findings on PFT,
Advanced tests for pulmonary function
should be done such as Gas dilution
techniques: Helium dilution method and
Nitrogen
washed
method,
Body
plethysmography, and Peak flowmetry. and
Intermittent oscillation (IOS) for cases of IBD
to detect another abnormalities.
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